Covered recipient · General Payments record
SUFIA JABEEN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,474.18
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $987.40 | 51 |
| Education | $102.32 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $307.52 | 19 |
| Lundbeck LLC | $187.22 | 7 |
| Alexion Pharmaceuticals, Inc. | $140.01 | 4 |
| PFIZER INC. | $124.36 | 6 |
| Lilly USA, LLC | $99.75 | 6 |
| EISAI INC. | $65.20 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.15 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.17 | 1 |
| TG THERAPEUTICS, INC. | $24.90 | 1 |
| Celgene Corporation | $21.82 | 1 |
| Teva Pharmaceuticals USA, Inc. | $18.44 | 1 |
| ARGENX US, INC. | $14.76 | 1 |
| EMD Serono, Inc. | $14.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.72 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387660 | CMS |
| ABBVIE INC. | $9.38 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387662 | CMS |
| ABBVIE INC. | $19.47 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387664 | CMS |
| ABBVIE INC. | $21.71 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387666 | CMS |
| ABBVIE INC. | $22.70 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387668 | CMS |
| ABBVIE INC. | $16.59 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387670 | CMS |
| ABBVIE INC. | $9.78 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387672 | CMS |
| ABBVIE INC. | $22.57 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387674 | CMS |
| ABBVIE INC. | $12.83 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387676 | CMS |
| ABBVIE INC. | $18.31 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387678 | CMS |
| ABBVIE INC. | $24.11 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387680 | CMS |
| ABBVIE INC. | $10.59 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387682 | CMS |
| ABBVIE INC. | $17.16 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387684 | CMS |
| ABBVIE INC. | $14.07 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387686 | CMS |
| ABBVIE INC. | $20.30 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387688 | CMS |
| ABBVIE INC. | $14.81 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387690 | CMS |
| ABBVIE INC. | $21.31 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387692 | CMS |
| ABBVIE INC. | $15.70 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387694 | CMS |
| ABBVIE INC. | $11.41 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107387696 | CMS |
| Alexion Pharmaceuticals, Inc. | $2.32 | 01/05/2024 | Education | Undisputed | 01/23/2026 | 1093885316 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.91 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094034203 | CMS |
| Alexion Pharmaceuticals, Inc. | $15.78 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093900887 | CMS |
| Alexion Pharmaceuticals, Inc. | $100.00 | 06/07/2024 | Education | Undisputed | 01/23/2026 | 1093977970 | CMS |
| ARGENX US, INC. | $14.76 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142143019 | CMS |
| Celgene Corporation | $21.82 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101108974 | CMS |
| Eisai Inc. | $21.02 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822489 | CMS |
| Eisai Inc. | $24.24 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822491 | CMS |
| Eisai Inc. | $19.94 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822493 | CMS |
| EMD Serono, Inc. | $14.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120217478 | CMS |
| Lilly USA, LLC | $13.28 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135892602 | CMS |
| Lilly USA, LLC | $18.78 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135916591 | CMS |
| Lilly USA, LLC | $20.12 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135947907 | CMS |
| Lilly USA, LLC | $13.99 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135956149 | CMS |
| Lilly USA, LLC | $20.38 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135868779 | CMS |
| Lilly USA, LLC | $13.20 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135967017 | CMS |
| Lundbeck LLC | $26.51 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039429 | CMS |
| Lundbeck LLC | $25.44 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039431 | CMS |
| Lundbeck LLC | $24.74 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039433 | CMS |
| Lundbeck LLC | $28.90 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039435 | CMS |
| Lundbeck LLC | $28.24 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039437 | CMS |
| Lundbeck LLC | $29.16 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039439 | CMS |
| Lundbeck LLC | $24.23 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039441 | CMS |
| Novartis Pharmaceuticals Corporation | $21.90 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087128974 | CMS |
| Novartis Pharmaceuticals Corporation | $24.25 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087128976 | CMS |
| PFIZER INC. | $18.58 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131130141 | CMS |
| PFIZER INC. | $23.22 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131221552 | CMS |
| PFIZER INC. | $22.17 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131373455 | CMS |
| PFIZER INC. | $15.39 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131449868 | CMS |
| PFIZER INC. | $21.93 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131878844 | CMS |
| PFIZER INC. | $23.07 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131410482 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.17 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137768059 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.44 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151553406 | CMS |
| TG Therapeutics, Inc. | $24.90 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136882151 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.